| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.81 | 0.0009 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |